{"id":510124,"title":"Notice: Multiple additions to the Prescription Drug List (PDL) [2025-12-18] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T04:27:32.204000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-12-18.html","snippet":"Notice: Multiple additions to the Prescription Drug List (PDL) [2025-12-18] December 18, 2025 Our file number: 25-108167-776 The purpose of this Notice of Amendment is to announce the addition of bempedoic acid, bexagliflozin, izenivetmab, lecanemab, oritavancin, pirtobrutinib,…","rawSnapshotUrl":"/api/snapshots/raw/510124","browseUrl":"https://replay.healtharchive.ca/job-6/20260216042732/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-12-18.html#ha_snapshot=510124","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}